Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

Clinical trial NCT01154816 · COMPLETED

Trial details

NCT number: NCT01154816
Sponsor: Children's Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatoblastoma Previously Treated Childhood Rhabdomyosarcoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Kidney Neoplasm Recurrent Childhood Malignant Germ Cell Tumor Recurrent Childhood Rhabdomyosarcoma Recurrent Childhood Soft Tissue Sarcoma Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Neuroblastoma Recurrent Osteosarcoma

Start date: 2011-02-01
Primary completion: 2015-12-31
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.